These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 7494232)
1. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. Ikuno N; Soda H; Watanabe M; Oka M J Natl Cancer Inst; 1995 Dec; 87(24):1876-83. PubMed ID: 7494232 [TBL] [Abstract][Full Text] [Related]
2. [Effect of Shengjiang Xiexin Decoction on the Repair of Damaged Rat Intestinal Mucosa after Irinotecan Chemotherapy]. Wang J; Jia LQ; Tan HY; Pan L; Yu LL; Deng B Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1236-43. PubMed ID: 26677677 [TBL] [Abstract][Full Text] [Related]
3. Re:Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. Guffroy M; Hodge T J Natl Cancer Inst; 1996 Sep; 88(17):1240-1. PubMed ID: 8780636 [No Abstract] [Full Text] [Related]
4. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats. Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738 [TBL] [Abstract][Full Text] [Related]
5. Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats. Fittkau M; Voigt W; Holzhausen HJ; Schmoll HJ J Cancer Res Clin Oncol; 2004 Jul; 130(7):388-94. PubMed ID: 15160289 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Hagiwara T; Kakihata K; Hirohashi M; Nomura M; Nagai E Jpn J Cancer Res; 1995 Oct; 86(10):978-84. PubMed ID: 7493918 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells. Masumoto N; Nakano S; Esaki T; Fujishima H; Tatsumoto T; Niho Y Int J Cancer; 1995 Jul; 62(1):70-5. PubMed ID: 7601570 [TBL] [Abstract][Full Text] [Related]
8. Intestinal microflora and digestive toxicity of irinotecan in mice. Brandi G; Dabard J; Raibaud P; Di Battista M; Bridonneau C; Pisi AM; Morselli Labate AM; Pantaleo MA; De Vivo A; Biasco G Clin Cancer Res; 2006 Feb; 12(4):1299-307. PubMed ID: 16489087 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment. Nagano T; Yasunaga M; Goto K; Kenmotsu H; Koga Y; Kuroda J; Nishimura Y; Sugino T; Nishiwaki Y; Matsumura Y Clin Cancer Res; 2009 Jul; 15(13):4348-55. PubMed ID: 19509138 [TBL] [Abstract][Full Text] [Related]
10. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. Gibson RJ; Bowen JM; Inglis MR; Cummins AG; Keefe DM J Gastroenterol Hepatol; 2003 Sep; 18(9):1095-100. PubMed ID: 12911669 [TBL] [Abstract][Full Text] [Related]
11. Relevance of irinotecan hydrochloride-induced diarrhea to the level of prostaglandin E2 and water absorption of large intestine in rats. Kase Y; Hayakawa T; Togashi Y; Kamataki T Jpn J Pharmacol; 1997 Dec; 75(4):399-405. PubMed ID: 9469646 [TBL] [Abstract][Full Text] [Related]
12. A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis. Utsunomiya T; Tanaka T; Utsunomiya H; Umesaki N Int J Oncol; 2008 May; 32(5):991-1000. PubMed ID: 18425325 [TBL] [Abstract][Full Text] [Related]
14. Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients. Takeda Y; Kobayashi K; Akiyama Y; Soma T; Handa S; Kudoh S; Kudo K Int J Cancer; 2001 Apr; 92(2):269-75. PubMed ID: 11291056 [TBL] [Abstract][Full Text] [Related]
15. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531 [TBL] [Abstract][Full Text] [Related]
16. Novel agents that potentially inhibit irinotecan-induced diarrhea. Yang X; Hu Z; Chan SY; Chan E; Goh BC; Duan W; Zhou S Curr Med Chem; 2005; 12(11):1343-58. PubMed ID: 15975002 [TBL] [Abstract][Full Text] [Related]
17. Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Ikegami T; Ha L; Arimori K; Latham P; Kobayashi K; Ceryak S; Matsuzaki Y; Bouscarel B Cancer Res; 2002 Jan; 62(1):179-87. PubMed ID: 11782376 [TBL] [Abstract][Full Text] [Related]
18. Irinotecan-induced bile acid malabsorption is associated with down-regulation of ileal Asbt (Slc10a2) in mice. Shi AX; Zhou Y; Zhang XY; Zhao YS; Qin HY; Wang YP; Wu XA Eur J Pharm Sci; 2017 May; 102():220-229. PubMed ID: 28288854 [TBL] [Abstract][Full Text] [Related]
19. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T Cancer Res; 1996 Aug; 56(16):3752-7. PubMed ID: 8706020 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral irinotecan against neuroblastoma xenografts. Thompson J; Zamboni WC; Cheshire PJ; Richmond L; Luo X; Houghton JA; Stewart CF; Houghton PJ Anticancer Drugs; 1997 Apr; 8(4):313-22. PubMed ID: 9180383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]